The 14-kDa protein α-synuclein is closely associated with Parkinson's disease (PD), dementia with Lewy bodies (DLB), and other synucleinopathies such as multiple system atrophy, and even certain forms of Alzheimer's disease. Deciphering the biochemistry of αS in native systems is key to developing therapeutics.
Parkinson’s disease is the second most common neurological disorder and the fastest growing neurological disease in numerical terms, affecting approximately 1% of people over the age of 60 in high-income countries.
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
